Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 95%
filed 2026-05-26
The filing discloses the appointment of Andrew Penn as a member and Chair of the Board of Directors of SharonAI Holdings Inc., effective May 21, 2026. The disclosure includes Penn's extensive background as former CEO of Telstra Corporation Limited and AXA Asia Pacific Holdings, along with his current roles and honors. The appointment is accompanied by a Director Appointment Letter detailing equity compensation (40,000 initial RSUs plus 6,944 annual RSUs) and $165,000 annual cash compensation. This is a material executive appointment that would affect a reasonable investor's assessment of the company's governance and leadership.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-05-26
The filing discloses results of a shareholder vote at the May 21, 2026 Extraordinary General Meeting on three proposals: (1) authorization for a 1-for-10 share consolidation, (2) adoption of amended articles of association, and (3) approval of the 2026 Equity Incentive Plan. Item 5.07 explicitly presents vote tallies (For, Against, Abstentions) for each proposal, which is the core disclosure requirement for shareholder vote results. The share consolidation and equity plan approval are material corporate actions affecting shareholders.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-26
The filing discloses that Worksport Ltd. secured a U.S. patent for an "industry-first" Zerofrost Heat Pump through its subsidiary Terravis Energy. While this represents a material intellectual property achievement that could affect investor assessment of the company's competitive position and product pipeline, it does not fit neatly into the standard 8-K event taxonomy (not earnings, M&A, executive changes, impairment, litigation, or other defined categories). The patent grant is disclosed via Item 7.01 (Regulation FD Disclosure) rather than a dedicated Item, suggesting the company classified it as a material event outside standard categories.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-05-26
The filing discloses a press release regarding "novel direct-acting antivirals" under Item 7.01 (Regulation FD Disclosure). Without access to the actual press release content (Exhibit 99.1), the materiality and specific event type cannot be definitively determined. The disclosure could relate to clinical trial results, product development milestones, or other significant pharmaceutical developments. Given the uncertainty about the substantive content and the lack of a more specific event category that clearly fits, "other_material" is the most appropriate classification, with moderate confidence reflecting the information gap.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-26
The filing discloses Item 5.07 results from the Annual Meeting of Shareholders held on May 20, 2026, including final vote tabulations for the election of two Class B Directors (Yvonne L. Murphy and William J. Nance) and ratification of Whitley Penn LLP as independent auditor. These are standard shareholder voting outcomes that are material to investors' understanding of corporate governance and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-26
The filing discloses Item 5.07 results from Portsmouth Square's Fiscal 2025 Annual Meeting of Shareholders held on May 20, 2026, including final vote tabulations for the election of five directors (John V. Winfield, William J. Nance, Yvonne L. Murphy, Steve Grunwald, and Andrew J. Kaplan) and ratification of Whitley Penn LLP as independent auditor. This is a routine but material shareholder vote disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
The filing discloses amendments to the Certificate of Incorporation and Bylaws that materially restrict stockholder rights. Specifically, Section C of Article VII eliminates stockholders' ability to take action by written consent and requires all stockholder actions to occur at duly called meetings. This is a material governance change that affects the rights and protections of security holders, though it does not fit neatly into the standard event taxonomy categories.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 75%
filed 2026-05-26
The filing discloses two material events: (1) a private placement of 500,000 shares for $500,000 (Item 1.01, 3.02), and (2) a Nasdaq deficiency letter on May 26, 2026 notifying the Company it failed to maintain the minimum $2.5 million stockholders' equity requirement under Listing Rule 5550(b)(1) (Item 3.01). While the private placement itself is a dilutive issuance, the delisting risk is the more material and time-sensitive disclosure—the Company has 45 days to submit a compliance plan or face potential delisting. The deficiency letter represents a direct threat to continued listing and would materially affect investor assessment of the registrant's viability.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-26
Lipocine disclosed presentation of Phase 3 clinical trial results for LPCN 1154 (oral brexanolone) for postpartum depression treatment at the ASCP Annual Meeting on May 26, 2026. While this represents material clinical progress for a biopharmaceutical company's lead candidate, it does not fit neatly into the standard taxonomy categories—it is neither an earnings release, M&A activity, executive change, nor a negative event like impairment or litigation. The disclosure of positive Phase 3 data would materially affect investor assessment of the company's pipeline prospects and regulatory pathway.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
The filing discloses a court-appointed receivership over the company (appointed September 18, 2024) and the filing of a Seventh Interim Report by the Receiver describing ongoing receivership activities, including resignation of the independent auditor, audit status issues for fiscal years 2023-2024, misappropriated funds, and pending litigation. While receivership is a terminal financial event, it does not fit neatly into the bankruptcy_filing category (which typically refers to formal bankruptcy proceedings under Chapter 7 or 11) nor any other specific taxonomy event. This is a material disclosure affecting investor assessment of the registrant's viability and control.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-05-26
Item 3.01 discloses that Vestand Inc. received a Staff Delisting Determination from Nasdaq on May 19, 2026, initiating a process that could result in delisting of the Company's Class A Common Stock due to failure to file delinquent quarterly and annual reports (September 2025 10-Q, 2025 10-K, and March 2026 10-Q). The filing explicitly states that if the Company's requests for stay and extension are not granted, "the Company's shares of Class A Common Stock will be delisted from the Nasdaq stock exchange." This is a clear delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-26
Item 5.02
Anthony Catalano was appointed as Chief Operating Officer on May 14, 2026, with a detailed employment agreement specifying $400,000 base salary, $50,000 sign-on bonus, equity awards of 0.30% of outstanding shares, and severance provisions. While the section also mentions Michael Miller's transition to Chief Technology and Products Officer, the principal disclosed action centers on Catalano's appointment to a C-suite role with material compensation and equity arrangements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Pinterest's May 21, 2026 annual meeting. The filing reports voting outcomes on four proposals: election of four Class I directors (Chip Bergh, Gokul Rajaram, Emily Reuter, Marc Steinberg), advisory approval of named executive officer compensation, frequency of future advisory compensation votes (determined to be annual), and ratification of Ernst & Young LLP as independent auditor. All proposals passed with substantial majorities, and the specific vote tallies for each matter are provided.
View raw filing on EDGAR →
8-K
Restatement
confidence 95%
filed 2026-05-26
Item 4.02
The filing explicitly discloses non-reliance on the Annual Report on Form 10-K for fiscal year 2025 due to identified errors in bank and credit card statement accounting. The Company is preparing a Form 10-K/A amendment to correct material misstatements including an $83,422 understatement of expenses, $121,122 understatement of liabilities, and $40,000 overstatement of paid-in capital. This is a classic financial restatement under Item 4.02, material to investors assessing the registrant's financial position and internal controls.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-26
Item 2.01
ESG Inc. completed a split-off and share exchange transaction on May 26, 2026, transferring 100% of ESG China Limited (a subsidiary) in exchange for the redemption and cancellation of 10,432,800 shares of common stock. The transaction materially alters the company's asset base, operational scope, and capital structure by separating the China business and retiring a significant portion of outstanding shares.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
Item 8.01
This Item 8.01 discloses the closing of a commercial mortgage-backed securitization (CMBS) transaction on May 26, 2026, involving the issuance of approximately $729.9 million in certificates by Benchmark 2026-V22 Mortgage Trust. While the filing describes the transaction structure, underwriters, and credit risk retention arrangements under Regulation RR, it does not fit neatly into the standard 8-K event taxonomy. The disclosure is material to investors as it documents a significant securitization closing with multiple certificate classes and substantial principal amounts, but the event is best classified as "other_material" rather than a more specific category like ma_activity, since it represents the closing of a securitization vehicle rather than a traditional acquisition or disposition by the registrant itself.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-26
Item 8.01
The filing discloses entry into underwriting and certificate purchase agreements on May 21, 2026, for the sale of approximately $832.6 million in commercial mortgage pass-through certificates (publicly and privately offered). While structured as a securitization rather than a traditional M&A transaction, this represents a material capital-raising and asset acquisition activity—the Registrant is acquiring 27 commercial and multifamily mortgage loans from Wells Fargo Bank, Bank of America, Morgan Stanley, and JPMorgan Chase, funded by the certificate issuances. The transaction is scheduled to close June 11, 2026, and involves multiple underwriters and servicers, making it a material financing and asset acquisition event.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
Item 8.01
The Board approved a $200 million share repurchase program, which is a material capital allocation decision affecting shareholder value and the company's financial position. While share repurchases are common corporate actions, a $200 million program represents a significant commitment of available cash and would affect a reasonable investor's assessment of capital strategy and financial flexibility. This does not fit neatly into the more specific event categories (it is not an earnings release, M&A activity, executive change, or financial restatement), making "other_material" the appropriate classification.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-26
Item 2.02
The Cato Corporation issued a press release on May 21, 2026 disclosing financial results for the first quarter ending May 2, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
The company held its Annual Meeting on May 21, 2026 and disclosed voting results for three proposals: election of three directors, advisory approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-26
Item 3.02
The filing discloses an unregistered sale of 7,000 shares of Series C Convertible Preferred Stock for $6,990,000 completed on May 20, 2026, under Section 4(a)(2) and Regulation D Rule 506(b). The preferred shares are convertible into common stock, making this a dilutive equity issuance. The substantial purchase price and convertible nature of the securities indicate material capital raising activity typical of Item 3.02 disclosures.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-26
Item 3.02 discloses an unregistered sale of 11,364 common shares of beneficial interest for approximately $0.3 million at $23.32 per share, exempt under Section 4(a)(2) and Regulation D Rule 506. This is a private placement of equity securities that dilutes existing shareholders and is material to investors assessing the fund's capital structure and share count.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-26
Item 2.02
The filing discloses CSW Industrials' financial results for the fiscal fourth quarter ended March 31, 2026, via a press release furnished as Exhibit 99.1. This is a standard quarterly earnings release under Item 2.02, which is material to investors as it provides the company's periodic financial performance and results of operations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-26
Item 1.01
Octave Intelligence completed a spin-off distribution from Hexagon AB on May 22, 2026, whereby Hexagon shareholders received Octave shares in a 1-for-10 ratio. The transaction involved entry into multiple material definitive agreements (Distribution Agreement, Tax Disaffiliation Agreement, Employee Matters Agreement, Master Transition Services Agreement, and Registration Rights Agreement) and constitutes a fundamental change of control and separation event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-26
Item 2.03
Octave Intelligence entered into a significant credit facility ($500M revolving + $350M USD + €150M term loans) on April 27, 2026, with full drawdown of the Term Loan Facility and partial drawdown of the Revolving Credit Facility to fund a $625 million cash payment to Hexagon in connection with the spin-off distribution.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-05-26
Item 4.01
The Audit Committee dismissed PricewaterhouseCoopers AB (PwC Sweden) as the independent registered public accounting firm and appointed PricewaterhouseCoopers LLP, United States (PwC US) as the new auditor effective immediately after the Distribution, reflecting the company's transition to independent public company status.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-05-26
Item 5.02
The Compensation Committee approved two compensatory arrangements on May 20, 2026: (1) one-time transaction bonuses totaling $2.85 million for named executive officers (Mattias Stenberg $950,000, Benjamin Maslen $800,000, Anthony Zana $800,000, Scott Moore $300,000) with repayment conditions tied to voluntary termination within one year; and (2) adoption of the Octave Intelligence plc Executive Annual Incentive Plan effective January 1, 2026, establishing a framework for annual cash incentive awards based on performance goals.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
Item 8.01
Strive announced a significant bitcoin purchase of 1,109 BTC at ~$76,989 per coin during May 19-22, 2026, along with material changes to its balance sheet composition (cash, bitcoin holdings, and equity issuances). The company also disclosed plans to refresh its ATM programs. While this reflects treasury management and asset allocation decisions rather than a discrete event type (M&A, litigation, restatement, etc.), the scale of the bitcoin acquisition and the resulting changes to shareholder equity structure would materially affect a reasonable investor's assessment of the company's financial position and strategy.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-05-26
Item 5.02
Paul R. Hibbert departed as Chief Supply Chain Officer effective June 1, 2026. The disclosure notes his severance eligibility under the Executive Severance Plan.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-26
Item 7.01
Anthony Freve was appointed as Chief Supply Chain Officer effective June 1, 2026, succeeding Paul R. Hibbert in this key operational leadership role.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-05-26
Item 1.01
Senti Biosciences issued $10.0 million in Senior Secured Convertible Notes to Celadon Partners SPV 24 on May 20, 2026, pursuant to a Securities Purchase Agreement. The convertible notes are dilutive securities that can convert to equity, materially affecting shareholder equity and voting power.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
This is a clear disclosure of shareholder voting results from Mondelez's May 20, 2026 annual meeting of shareholders under Item 5.07. The filing presents detailed voting tallies for five matters: election of 10 directors, advisory approval of named executive officer compensation, ratification of PricewaterhouseCoopers LLP as independent auditors, and two shareholder proposals (both rejected). The disclosure of director elections and auditor ratification are material governance events that affect investor understanding of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
Zebra Technologies held its Annual Meeting of Stockholders on May 19, 2026, with voting results on four proposals: election of four Class III directors, advisory vote on named executive officer compensation, approval of the 2026 Long-Term Incentive Plan, and ratification of Ernst & Young LLP as independent auditors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-26
Item 2.02
Digital Turbine issued a press release on May 26, 2026 announcing financial results for the quarter ended March 31, 2026, with the announcement attached as Exhibit 99.1. This is a standard quarterly earnings disclosure under Item 2.02, which is the designated Item for results of operations and financial condition. The filing explicitly references the press release and forward-looking statements typical of earnings announcements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
This is a clear disclosure of shareholder vote results from Finward Bancorp's Annual Meeting of Shareholders held on May 22, 2026, filed under Item 5.07. The filing presents detailed voting outcomes for three proposals: election of three directors (Benjamin J. Bochnowski, Robert E. Johnson III, and Martin P. Alwin to three-year terms), ratification of Forvis Mazars, LLP as independent auditor, and an advisory vote on executive compensation. All three proposals passed with substantial majorities. This is a routine but material disclosure required by Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Shareholders held on May 26, 2026. The filing reports voting outcomes for two proposals: (i) reelection of two Class II directors (Brian Sedrish and James Fagan) and (ii) ratification of CohnReznick LLP as independent auditor. Both proposals passed with substantial majorities. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-05-26
Item 5.02
Christopher P. Litterio, who held three senior roles (General Counsel, Secretary, and Senior Vice President of Human Resources), informed the company on May 19, 2026 of his plan to retire. The disclosure centers on the departure of a named executive officer from multiple material positions, making this an executive departure event. The retirement of a General Counsel and senior HR executive is material to investors as it affects corporate governance and organizational leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 93%
filed 2026-05-26
Item 5.02
Nicholas Johnson was appointed as Chief Executive Officer of Medifast Inc., effective June 1, 2026, succeeding Daniel R. Chard who transitions to non-executive Chairman. The appointment was approved by the Board on May 20, 2026, and disclosed via press release.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
At the Annual Meeting of stockholders, four proposals were submitted to a vote and all passed with substantial majorities: (i) election of seven directors to the Board, (ii) ratification of RSM US LLP as independent auditor, (iii) advisory vote on named executive officer compensation, and (iv) approval of the Amended 2012 Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Ardent Health's Annual Meeting of Stockholders held on May 20, 2026. The filing reports voting outcomes on three matters: election of 11 directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. All three votes passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and executive accountability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
This is a clear disclosure of shareholder vote results from the May 22, 2026 Annual Meeting of Stockholders, with detailed voting tallies for five proposals including director elections, auditor ratification, executive compensation approval, and stock plan amendments. Item 5.07 explicitly requires disclosure of shareholder voting results, and the material outcomes (all proposals approved) affect investor understanding of governance and capital allocation decisions.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-26
Item 1.01
Lincoln International entered into material definitive agreements in connection with its initial public offering on May 19, 2026, including the Fourth Amended and Restated Limited Partnership Agreement, Tax Receivable Agreement, and Voting Agreement, constituting a material change of control event affecting the company's ownership and governance structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-26
Item 8.01
Lincoln International completed an initial public offering of 24,207,486 shares of Class A common stock at $20.00 per share, generating gross proceeds of $473.7 million, and issued approximately 81 million shares of Class B and Class C common stock to existing and controlling partners under Section 4(a)(2) exemption, materially diluting existing shareholders.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-26
Item 5.02
The company appointed two new directors, M. Christie Smith and John W. Oleniczak, effective May 19, 2026, with specified committee assignments, and disclosed employment agreements with the CEO and President.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-05-26
Item 3.03
The company disclosed a material modification to rights of security holders, with the substance incorporated by reference from Item 5.03, relating to governance or capital structure changes affecting security holder rights.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-26
Item 5.07
Precision BioSciences held its annual meeting of stockholders on May 21, 2026, with shareholders voting on six proposals including director elections (Melinda Brown and Geno Germano), auditor ratification (Deloitte & Touche LLP), executive compensation approval, and amendments to the 2019 Incentive Award Plan and Certificate of Incorporation. All proposals were approved by shareholders.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-26
Item 5.02
Peloton appointed Siddharth Thacker as Chief Financial Officer effective June 22, 2026, replacing interim CFO Saqib Baig. The appointment includes a base salary of $635,000, bonus eligibility, and $8,000,000 in equity awards.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-26
Item 2.03
This Item 2.03 disclosure describes the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of New York. While the filing explicitly states "consolidated obligations issuance is material to the Bank," the disclosure is primarily informational and regulatory in nature—explaining the structure, joint and several liability framework, and reporting methodology for consolidated obligations rather than announcing a specific new debt issuance event. The absence of a Schedule A with specific issuance details and the emphasis on general policies and disclaimers suggest this is a routine periodic disclosure of the Bank's debt issuance program rather than a discrete material event triggering Item 2.03.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-05-26
Item 8.01
The filing discloses results of the Company's 2026 annual meeting of stockholders held on May 22, 2026. Although no votes were formally cast due to lack of quorum (only 219.7M of 722.2M shares represented), the Company received and reports proxy voting instructions on director elections, executive compensation advisory votes, auditor ratification, and compensation frequency—the standard matters voted at annual meetings. The disclosure of proxy voting patterns, even absent a quorum, constitutes shareholder vote results material to investors regarding governance and director continuity.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-26
Item 8.1
The filing discloses two significant Board-approved actions: (1) launch of a digital asset treasury 2.0 program involving cryptocurrency trading and a Coinbase account, and (2) assignment to the Company of up to $10 million from a $57.9 million judgment awarded to CEO Vikram Grover against NSAV et al., with consideration to be paid in Company Notes, Preferred Stock, or Common Shares. While the judgment assignment could signal potential dilutive issuance or material litigation settlement, the disclosure centers on Board approval of strategic initiatives and a contingent asset acquisition rather than a completed transaction or traditional event type. The cryptocurrency treasury program and judgment monetization represent material strategic decisions affecting shareholder value, but do not fit cleanly into the standard taxonomy categories.
View raw filing on EDGAR →